Clinical trial
Single Dose of Gonadotropin Releasing Hormone (GnRH)-Agonist as an Adjuvant Luteal Phase Support in Hormone Replacement Therapy (HRT) Frozen Embryo Transfer (FET) Cycles Prospective Comparative Study
NCT07653282 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Dose of Gonadotropin Releasing Hormone (GnRH)-Agonist as an Adjuvant Luteal Phase Support in Hormone Replacement Therapy (HRT) Frozen Embryo Transfer (FET) Cycles Prospective Comparative Study
- Lead sponsor
- Assiut University
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- August 1, 2026
- Completion date
- August 1, 2028
- Enrollment
- 122 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gnrh agonist